User login
- /content/new-analysis-bolsters-metformin-first-line-type-2-diabetes
- /familypracticenews/article/108141/diabetes/new-analysis-bolsters-metformin-first-line-type-2
- /internalmedicinenews/article/108141/diabetes/new-analysis-bolsters-metformin-first-line-type-2
- /clinicalendocrinologynews/article/108141/diabetes/new-analysis-bolsters-metformin-first-line-type-2
- /diabeteshub/article/108141/diabetes/new-analysis-bolsters-metformin-first-line-type-2-diabetes
- /ecardiologynews/article/108141/diabetes/new-analysis-bolsters-metformin-first-line-type-2-diabetes
- /cardiology/article/108141/diabetes/new-analysis-bolsters-metformin-first-line-type-2-diabetes
- /endocrinology/article/108141/diabetes/new-analysis-bolsters-metformin-first-line-type-2-diabetes
- /internalmedicine/article/108141/diabetes/new-analysis-bolsters-metformin-first-line-type-2-diabetes
- /familymedicine/article/108141/diabetes/new-analysis-bolsters-metformin-first-line-type-2-diabetes
- /type-2-diabetes-icymi/article/108141/diabetes/new-analysis-bolsters-metformin-first-line-type-2